advertisement

Topcon

Chen L 23

Showing records 1 to 23 | Display all abstracts from Chen L

90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Li X
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Liu X
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Leng Y
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Li J
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Jiang Q
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Lin S; Xiao X
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Wang Z
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Luo J
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Luo P
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Wei W
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Zhang C
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Ling Y
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Chen L
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Fang L
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Wang Y
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Xiao H
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Wang H; Yue X
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Chen L; Huang J
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Shen C; Zhou Y
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Zhong Y
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Shi C
Frontiers in pharmacology 2020; 11: 1038
90603 Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa
Zhang Q
Experimental Eye Research 2020; 197: 108118
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Xie L
Frontiers in pharmacology 2020; 11: 1038

Issue 21-3

Change Issue


advertisement

Oculus